CN Stock MarketDetailed Quotes

688235 BeiGene, Ltd.

Watchlist
  • 164.00
  • +1.60+0.99%
Market Closed Dec 27 15:00 CST
226.99BMarket Cap-34.79P/E (TTM)

BeiGene, Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BeiGene, Ltd. Q3 2024 Earnings Date

Currency：HKDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
7.65B
7.79B
+134.93M
Beat Est.
+25.05%
+27.25%
+1.76%
EPS
--
-0.70
--
-155.84%
Analyst Rating
Strong Buy

Dec 28, 2024

BeiGene, Ltd. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.072B--
--2024/Q4-- / 1.041B--
Nov 13, 20242024/Q31.002B / 984.242M--
--2024/Q2929.166M / 809.185M--
--2024/Q1751.652M / 675.230M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.072B--
--2024/Q4-- / 1.041B--
Nov 13, 20242024/Q31.002B / 984.242M--
--2024/Q2929.166M / 809.185M--
--2024/Q1751.652M / 675.230M--

Unlock Free Earnings Estimates

BeiGene, Ltd. Earnings Reports

  • BeiGene Shenzhou Ltd. Third Quarter Report 2024

    Nov 12 11:00 ET

  • BeiGene Shenzhou Co., Ltd. 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • BeiGene Shenzhou Co., Ltd. 2024 Semi-Annual Report Summary

    Aug 29 12:00 ET

  • Hong Kong Stock Announcement: BeiGene Shenzhou Limited Interim Results Announcement for the Six Months Ended June 30, 2024

    Aug 27 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Strong Buy

    • Strong Buy

      76.92%

    • Buy

      15.39%

    • Hold

      7.69%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday+0.71%
    Innovative Drugs
    Innovative Drugs
    Intraday+0.47%